Joshi Acosta

Joshi Acosta

Auto-generated profile, based on publicly available information

Joshi Acosta

Centro Nacional de Salud Pública, Instituto Nacional de Salud, Jirón Cápac Yupanqui 1400-Jesús María, Lima 11, Lima, Peru

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
MMMaría Merino
María Merino
JAJoshi Acosta
Joshi Acosta
MPMargarita Poza
Margarita Poza
FSFrancisca Sanz
Francisca Sanz
ABAlejandro Beceiro
Alejandro Beceiro
GBGermán Bou
Germán Bou
A clinical strain of Acinetobacter calcoaceticus resistant to carbapenems was isolated from a blood culture sample from an inpatient in a hospital in Madrid (Spain) during a large outbreak of infection (affecting more than 300 inpatients), caused by a multidrug-resistant Acinetobacter baumannii clone. The carbapenem resistance in both the A. calcoaceticus and A. baumannii clones was due to a bla OXA-24 gene harbored in different plasmids. The plasmids were fully sequenced, revealing the presence of site-specific recombination binding sites putatively involved in mobilization of the bla OXA-24 gene. Comparison of plasmids contained in the two strains revealed possible horizontal transmission of resistance genes between the Acinetobacter species.

1 November 2009 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
EVEsther Viedma
Esther Viedma
Carlos JuanCarlos Juan
Carlos Juan
JAJoshi Acosta
Joshi Acosta
LZLaura Zamorano
Laura Zamorano
JOJoaquín R. Otero
Joaquín R. Otero
AOAntonio Oliver
Antonio Oliver
The mechanisms responsible for the increasing prevalence of colistin-only-sensitive (COS) Pseudomonas aeruginosa isolates in a Spanish hospital were investigated. Pulsed-field gel electrophoresis revealed that 24 (50%) of the studied isolates belonged to the same clone, identified as the internationally spread sequence type 235 (ST235) through multilocus sequence typing. In addition to several mutational resistance mechanisms, an integron containing seven resistance determinants was detected. Remarkably, the extended-spectrum β-lactamase GES-1 and its Gly170Ser carbapenem-hydrolyzing derivative GES-5 were first documented to be encoded in a single integron. This work is the first to describe GES enzymes in Spain and adds them to the growing list of β-lactamases of concern (PER, VIM, and OXA) detected in ST235 clone isolates.

1 July 2011 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
JAJ. Acosta
J. Acosta
MCM. Catalan
M. Catalan
APA. del Palacio-Peréz-Medel
A. del Palacio-Peréz-Medel
DLD. Lora
D. Lora
JMJ.-C. Montejo
J.-C. Montejo
APA. del Palacio
A. del Palacio
Diagnosis of fungal pneumonia (FP) in critically ill patients is challenging. Circulating biomarkers for the diagnosis of FP have limitations and the combination of different assays in serum samples and directly from the target organ may further improve the diagnosis of FP. We prospectively assessed the diagnostic utility of paired galactomannan (GM) in bronchoalveolar lavage fluid (BAL) and serum GM and (1→3)–β–d-glucan (BG) assays in critically ill patients at risk of FP. Patients with FP were classified according to European Organisation for Research and Treatment of Cancer-Mycoses Study Group criteria, with modifications. Out of 847 admissions, 51 patients were eligible. There were nine invasive aspergillosis (IA) cases (four proven, five probable), three proven Pneumocysitis jirovecii pneumonia (PJP) cases and one mixed FP case (probable IA and proven PJP). The diagnostic accuracy as given by the area under the receiver operating characteristic curve in IA cases (proven and probable) for GM in BAL was 0.98 (95% CI, 0.94–1.00), whilst for GM and BG in serum it was 0.85 (95% CI, 0.74–0.96) and 0.815 (95% CI, 0.66–0.96), respectively. For IA cases (proven and probable) AUC for GM in BAL was significantly higher than GM and BG in serum (p 0.025 and p 0.032, respectively). In one of four proven and one of six probable IA cases, GM in serum remained negative, whereas GM in BAL was positive. In patients with IA, GM (90%) and BG (80%) appeared a mean of 4.3 days (range, 1–10 days) before Aspergillus was cultured. GM detection in BAL appears to improve the diagnosis of IA in critical patients.

1 January 2022 in The International Journal of Tuberculosis and Lung Disease
Verified
Journal Article
Open access
JAJ. Acosta
J. Acosta
PFP. Flores
P. Flores
MAM. Alarcón
M. Alarcón
MGM. Grande-Ortiz
M. Grande-Ortiz
LML. Moreno-Exebio
L. Moreno-Exebio
ZPZ. M. Puyen
Z. M. Puyen
BACKGROUND: Adherence to TB treatment and therefore treatment success could be improved using digital adherence technology.OBJECTIVE: To evaluate the effectiveness of a medication event reminder monitor system (MERM) on treatment success and treatment adherence in patients with drug-susceptible pulmonary TB in Perú.METHODS: This was an experimental, randomised, open-label, controlled study conducted among patients in the second phase of TB treatment. The intervention group received their medications through MERM with the support of a treatment monitor, whereas the control group used the usual strategy. Participants were followed until they completed the 54 doses of the second phase of treatment.RESULTS: The study included 53 patients in each group; four in the intervention group withdrew from the study. Treatment success was significantly more frequent in the MERM group (RR 1.15, 95% CI 1.02–1.30; P = 0.0322). There was no significant difference in the adherence outcomes; however, the percentage of patients who missed at least one dose and patients with more than 10% of total doses missed were lower in the intervention group.CONCLUSION: The use of MERM in the second phase of treatment showed a significant improvement in the treatment success rate in patients with drug-susceptible pulmonary TB.

3 August 2011 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JAJ. Acosta
J. Acosta
MCM. Catalan
M. Catalan
APA. Palacio-Pérez-Medel
A. Palacio-Pérez-Medel
JMJ.-C. Montejo
J.-C. Montejo
JDJ. De-La-Cruz-Bértolo
J. De-La-Cruz-Bértolo
APA. Palacio
A. Palacio

1 June 2011 in Emerging Infectious Diseases
Verified
Journal Article
Open access
JAJoshi Acosta
Joshi Acosta
MMMaría Merino
María Merino
EVEsther Viedma
Esther Viedma
MPMargarita Poza
Margarita Poza
FSFrancisca Sanz
Francisca Sanz
GBGermán Bou
Germán Bou
In February 2006, a patient colonized with a multidrug-resistant sequence type 56 Acinetobacter baumannii strain was admitted to a hospital in Madrid, Spain. This strain spread rapidly and caused a large outbreak in the hospital. Clinicians should be alert for this strain because its spread would have serious health consequences.